Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 205-209

  Biesterfeld, Stefan ^a   Schuh, Silke ^a   Muys, Leon ^a   Rath, Werner ^a   Mittermayer, Christian ^a   Schröder, Willibald ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Epidermal growth factor receptor; Squamous cell carcinoma; Uterine cervix

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EVALUATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PREGNANCY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0032622474     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.1.205     Document Type: Article

References (39)

1. Christopherson WM and Scott MA: Trends in mortality in uterine cancer in relation to mass screening. Acta Cytol 21: 5-9, 1977.
2. Dickinson L, Mussey ME and Kurland LT: Evaluation of the effectiveness of cytologic screening for cervical cancer. II. Survial parameters before and after inception of screening. Mayo Clin Proc 47: 545-549, 1972.
3. Devesa SS, Young JL, Brinton LA and Fraumeni JF: Recent trends in cervix uteri cancer. Cancer 64: 2184-2190, 1989.
4. Rosai J: Ackerman's Surgical Pathology. Vol. 2. 8th edition. Mosby-Year Book Inc., St. Louis, MO, pp 1367-1368, 1996.
5. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L and Mangioni C: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350: 535-540, 1997.
6. Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N and di Paola G: Long-term follow-up of the first randomized trial using neo-adjuvant chemoterapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 67: 61-69, 1997.
7. National Institutes of Health Consensus Development Conference Statement on Cervical Cancer: Consensus statement. Gynecol Oncol 66: 351-361, 1997.
8. Shingleton HM and Orr JW: Cancer of the Cervix. Chapter 6: Diagnosis, staging, and selection of therapy for invasive tumors. J.B. Lippincott, Philadelphia, pp93-122, 1995.
9. Peto M, Tolle-Ersu I, Kreysch HG and Klock G: Epidermal growth factor induction of human papillomavirus type 16 E6/E7 mRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J Gen Virol 76: 1945-1958, 1995.
10. Wistuba I, Roa I, Araya J, Villaseca M, Chavez F and Capurro I: Immunohistochemical expression of epidermal growth factor receptor (EGFR) in epidermoid carcinoma of the cervix uteri and its precursor lesions. Rev Chil Obstet Ginecol 59: 116-122, 1994.
11. Stellwag B, Scheidel P, Pfeiffer D and Hepp H. Der EGF-Rezeptor und EGF-ahnliche Aktivität als Prognosefaktoren beim Zervixkarzinom. Geburtshilfe Frauenheilkd 53: 177-181, 1993.
12. Kristensen GB, Holm R, Abeler VM and Trope CG: Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study. Cancer 78: 433-440, 1996.
13. Nishikawa K, Rosenblum MG, Newman RA. Pandita TK, Hittelman WN and Donate NJ: Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. Cancer Res 52: 4758-4765, 1992.
14. Donato NJ, Martin CA, Perez M, Newman RA, Vidal JC and Etcheverry M: Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanism. Biochem Pharmacol 51: 1535-1543, 1996.
15. Hermanek P, Hutter RVP, Sobin LH, Wagner G and Wittekind CH. TNM Atlas. 4th edition. Springer, Berlin, 1997.
16. Creasman WT: New gynecologic cancer staging. Gynecol Oncol 58: 157-158, 1995.
17. Schröder W, Biesterfeld S, Zillessen S and Rath W: Epidermal growth factor receptor - immunohistochemical detection and clinical significance for treatment of primary breast cancer. Anticancer Res 17: 2799-2802, 1997.
18. Sainsbury JRC, Sherbert GV, Farndon JR and Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet i: 364-366, 1985.
19. Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CBM and Benraad TJ: Epidermal growth factor receptor negative tumors are predominantly confined to the subgroup of estradiol receptor positive human primary breast cancers. Cancer Res 51: 4544-4548, 1991.
20. Libermann TA, Razon N, Bartal AD, Yarden Y, Schlesinger J and Soreq H: Expression of epidermal growth factor receptor in human brain tumors. Cancer Res 44: 753-760, 1984.
21. Hendler Fj and Ozanne BW: Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74: 647-651, 1984.
22. Yukawa M, Fujimori T, Hirayama D, Idei Y, Ajiki T, Kawai K, Sugiura R, Maeda S and Nagasako K: Expression of oncogene products and growth factors in early gallbladder cancer, advanced gallbladder cancer, and chronic cholecystitis. Hum Pathol 24: 37-40, 1993.
23. Lee CS and Pirdas A: Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours. Path Res Pract 191: 1087-1091, 1995.
24. Lemoine NR, Hughes CM, Barton CM, Poulson R, Jeffrey RE, Klöppel G, Hall PA and Gullick WJ: The epidermal growth factor receptor in human pancreatic cancer. J Pathol 166: 7-12, 1992.
25. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ho H and Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 48: 137-141, 1988.
26. D'Agnano X, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A and Zupi G: DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest 72: 432-438, 1995.
27. Hirose K, Arai M and Nakagawara G: Expression of human epidermal growth factor and DNA ploidy pattern in gastric carcinoma. Nippon Geka Gakkai Zasshi 92: 122-126, 1991.
28. Lagrange JL, Francoual M, Formento JL, del Guidice P. Bensadoun RJ, Teissier E. Ettore F, Gillet JY, Namer M and Milano G: Demonstration and characterization of EGF receptors in cancer of the uterine cervix. Bull Cancer Paris 80, 219-224, 1993.
29. Sugimura M, Kobayashi H, Kanayama N and Terao T: Immunohistochemical study on the expression of epidermal growth factor receptor (EGF-R) in invasive cervical cancer of the uterus. Nippon Sanka Fujinka Gakkai Zasshi 44: 689-694, 1992.
30. Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M and Sugimori H: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 40: 147-151, 1991.
31. Kim JW, Kim YT, Kim DK, Song CH and Lee JW: Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol 60: 283-287, 1996.
32. Furugen Y: Immunohistochemical studies on epidermal growth factor receptor (EGF-R) in gynecological malignant tumor. Nippon Sanka Fujinka Gakkai Zasshi 43: 410-416, 1991.
33. Ueda M: Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer. Nippon Sanka Fujinka Gakkai Zasshi 41: 1401-1408, 1989.
34. Maruo T, Yamasaki M, Ladines-Llave CA and Mochizuki M: Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer 69: 1182-1187, 1992.
35. Muto Y, Fujii J, Shidoji Y, Moriwaki H, Kawaguchi T and Noda T: Growth retardation in human cervical dysplasia-derived cell lines by beta-carotene through down-regulation of epidermal growth factor receptor. Am J Clin Nutr 62 (Suppl): 1535S-1540S, 1995.
36. Pateisky N, Schatten C, Vavra N, Ehrebock P, Angelberger P, Barrada M and Epenetos A: Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancer. Wien Klin Wochenschr 103: 654-656, 1991.
37. Dellas A, Schultheiss E, Almendral AC, Torhorst J and Gudat F: Assessment of EGFR and TGF-α expression in relationship to HPV status and Ki-67 distribution in cervical intraepithelial neoplasms. Int J Cancer 69: 165-169, 1996.
38. Hembree JR, Agarwal C and Eckert RL: Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1. Cancer Res 54: 3160-3166, 1994.
39. Tervahauta A, Syrjänen S and Syrjänen K: Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix. Int J Gynecol Pathol 13: 234-240, 1994.